Balneotherapy for breast cancer patients on hormone therapy
Part of Cancer, Skin clinical trials.
This trial tests if balneotherapy (therapeutic baths in mineral water) can help reduce muscle and joint pain caused by hormone therapy in premenopausal women with early-stage breast cancer. You may be able to join if you are on a specific type of hormone therapy and have developed new pain since starting it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a premenopausal woman with early-stage breast cancer (stages I, II, or III) that is hormone receptor-positive.
- You are currently on a hormone therapy that includes both ovarian suppression and an aromatase inhibitor for at least 3 months.
- You have developed muscle or joint pain that started or got worse after beginning this hormone therapy (pain score of at least 2 out of 10).
- You did not have chronic muscle or joint problems (like fibromyalgia) before starting hormone therapy.
- You do not have anxiety or depression that required medication before starting hormone therapy.
- You are not afraid of water, do not have severe incontinence, severe vein problems, epilepsy, or physical disabilities that would make water therapy difficult.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a supervised exercise program can improve quality of life for people with early-stage breast cancer who are currently taking hormone therapy (aromatase inhibitors with or without CDK4/6 inhibitors). It aims to see if exercise helps reduce side effects like fatigue and pain.
This trial tests whether a yoga program can help reduce joint and muscle pain caused by hormone therapy (like tamoxifen or aromatase inhibitors) in people with breast cancer. You must have finished your main treatments at least 12 weeks ago and have had pain for more than 3 months.
This trial tests a cognitive behavioral therapy (CBT) based program to help relieve joint and muscle pain caused by aromatase inhibitors, a common hormone therapy for breast cancer. It aims to improve your quality of life and reduce symptoms.
This trial tests whether two supportive medicines (duloxetine and furosemide) can help reduce muscle, bone, or joint pain caused by hormone therapy in people with early breast cancer. If you are having this side effect, the study aims to improve your daily comfort and quality of life.
This trial tests whether a CBD oral solution can help relieve joint pain caused by hormone therapy (aromatase inhibitors) in people with early breast cancer. It aims to improve your quality of life during treatment.
This trial studies whether a combined physical therapy, yoga, and patient education program can reduce pain in people with non-metastatic breast cancer who are taking hormone therapy. It may help with pain and day-to-day comfort while you continue hormone treatment.
Hear when a new Breast Cancer Early Stage Breast Cancer (Stage 1-3) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.